Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 879.00
+19.00 (2.21%)
Jun 25, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 56.95 billion as of June 25, 2026. Its market cap has increased by 621.03% in one year.
Market Cap
56.95B
Enterprise Value
55.10B
Revenue
25.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
879.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 56.95B, an increase of 925.04%. That is a compound annual growth rate of 175.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 56.95B | 183.89% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 161.86B |
| Lin BioScience | 32.55B |
| CHO Pharma | 28.04B |
| Oneness Biotech | 23.68B |
| Sunmax Biotechnology | 20.51B |
| TaiMed Biologics | 17.62B |
| Lumosa Therapeutics | 17.17B |
| Ever Supreme Bio Technology | 15.52B |